Key Highlights

  • Wide Open Agriculture shares were trading at $0.012 during the 13 November 2026 session, up 9.09%.
  • The company secured a $1.0 million Placement at $0.01 per share, with 100 million new shares subject to Shareholder approval.
  • The company is moving to an asset-light contract Manufacturing model and plans to resume Supply of its lupin ingredients.

During the Trading session on 13 November 2026, Wide Open Agriculture Ltd (ASX:WOA) shares were trading at $0.012, up 9.09%, while the S&P/ASX 200 was down 0.73% at 9,079.70 at 12:39 pm AEDT. Wide Open Agriculture develops and supplies proprietary lupin ingredients for customers in food and beverage markets. The share price move is linked to the company's announcement dated 13 November 2026 of a placement to fund its strategy.

$1 million placement secured

Wide Open Agriculture has secured firm commitments for a $1.0 million placement through the issue of 100 million new shares at $0.01 each. The placement attracted support from major existing shareholders and new sophisticated and professional investors. Directors and management have also proposed to take $129,000 of shares in lieu of accrued fees and salary, subject to shareholder approval.

Shift to an asset-light manufacturing model

The placement is intended to advance the company's transition to an asset-light contract manufacturing model. The company said this shift is central to a strategy aimed at reducing fixed manufacturing costs and building a more scalable business. The new Capital will support contract manufacturing validation, commercial development and the planned resumption of lupin ingredient supply to customers.

Cash position and tax incentive

The company held $1.1 million of cash at 30 September 2026. It also expects an R&D tax incentive rebate of about $1.2 million, net of costs, in December 2026. The announcement describes the placement as strengthening the funding position.

Sector context

Plant-based ingredient producers have faced pressure to reduce fixed production costs and to validate products with large food and beverage manufacturers. Contract manufacturing arrangements allow smaller ingredient businesses to scale production without owning all facilities, though they depend on partners meeting quality and Volume requirements.

Risks investors are watching

The placement is subject to shareholder approvals, and the issue of shares at one cent will increase the number of shares on issue. Resumption of lupin ingredient supply depends on contract manufacturing validation, which is not yet complete. Cash on hand is modest relative to the company's planned commercial development, and the expected tax rebate is not received until December.

What to watch ahead

Investors will look for the shareholder vote on the placement and director participation, progress on contract manufacturing validation and the timing of the first resumed lupin supply to customers. The receipt of the R&D tax incentive rebate in December will also be followed.

Final Word

Wide Open Agriculture's placement provides capital for its move to contract manufacturing and the return of lupin supply. Progress on validation and shareholder approvals will shape the next phase of its plan.